The criteria covered in 21 CFR Part 11 are not the only requirements that should be considered for compliant document management associated with clinical trials.
Knowing the question you’re trying to answer is the most important place to start when approaching metrics.
Forte’s expert statistician gives her thoughts and tips for organizations looking to track operational metrics. Her greatest advice: know thy question.
Webinar presenter responds to these questions and provides resources for additional guidance on clinical trial delegation of authority logs.
Learn methods for addressing some of the research industry’s most pressing challenges and gain insights about performance metrics, effort tracking and more.
Dr. Wendy Tate discusses the industry’s progress toward greater inclusivity in clinical trials and identifies the continued need for improved diversity in research.
Co-presenter, Dr. Wendy Tate, addresses attendee questions following Forte’s recent webinar on advertising clinical trials for patient recruitment.
AACI-CRI meeting attendees discuss methods for increasing efficiencies in clinical trials, including feasibility committees and workload assessment.
In this Q&A, Dr. Wendy Tate answers attendee questions from her webinar “Making Your Consent Forms Readable: The Why and the How.” Question topics include NPRM, federal regulations, cost language, central IRBs and more.